
The growth prospects of regenerative medicine market holds potential owing to rise in the number of potentially successful clinical trials, large unmet demands in several indications, and rise in the number of mergers & acquisitions. Moreover, emergence of stem cell technology, shortage of organs for transplantation, unexplored areas of nanotechnology, rise in the cases of degenerative illnesses, innovation in monitoring devices & surgical technologies are some of the factors prompting the growth of regenerative medicine market. These facts combined with other crucial data are taken from the market research report, included in Market Research Hub's (MRH) all-inclusive repository, titled, "Global Regenerative Medicine Market Analysis & Forecast to 2023; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries." Regenerative medicine market is estimated to record a CAGR of ~23% by 2023. The growth of regenerative medicine market will most likely be hampered by several factors such as strict regulations in some regions, amount of investment needed to back research & development, trials & commercialization, clinical research, and reimbursement policies. On the basis of region, Europe is predicted to grow substantially in the near future. Europe has immense potential to surpass different regions with regards to stem cell applications and this will become possible if Trump Administration prevents funding & legislation. This, in turn, will help to boost the market growth of regenerative medicines.